citric acid, anhydrous has been researched along with meropenem in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Abbas, HA; Goda, RM; Kadry, AA; Shaker, GH | 1 |
| Czuczwar, M; Fronczek, J; Gielicz, A; Górka, J; Kudliński, B; Nowak-Kózka, I; Polok, KJ; Seczyńska, B; Szczeklik, W | 1 |
3 other study(ies) available for citric acid, anhydrous and meropenem
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Catalytic Domain; Ciprofloxacin; Citric Acid; Drug Combinations; Drug Synergism; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Malates; Meropenem; Microbial Sensitivity Tests; Zinc | 2019 |
Concentration of meropenem in patients with sepsis and acute kidney injury before and after initiation of continuous renal replacement therapy: a prospective observational trial.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Anticoagulants; Chromatography, High Pressure Liquid; Citric Acid; Cohort Studies; Continuous Renal Replacement Therapy; Critical Illness; Female; Humans; Male; Meropenem; Middle Aged; Prospective Studies; Sepsis; Tandem Mass Spectrometry | 2020 |